Assessing the presence of oligoclonal IgM bands as a prognostic biomarker of cognitive decline in the early stages of multiple sclerosis

[Coll-Martinez C, Salavedra-Pont J, González-del-Rio M, Álvarez-Bravo, G] Girona Neuroimmumology and Multiple Sclerosis Unit, Neurology Department, Hospital Universitari de Girona Doctor Josep Trueta, Institut Català de la Salut (ICS), Girona, Spain. Santa Caterina Hospital, Salt, Girona, Spain. Neurodegeneration and Neuroimflammation Research Group, Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta, Salt, Spain. [Quintana E] Neurodegeneration and Neuroimflammation Research Group, Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta, Salt, Spain. Medical Sciences Department, University of Girona, Girona, Spain. REEM, Multiple Sclerosis Spanish Network, Instituo de Salud Carlos III, Madrid, Spain. [Buxó M] Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta, Salt, Spain. [Gómez I, Muñoz-San Martín, M] Neurodegeneration and Neuroimflammation Research Group, Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta, Salt, Spain. [Villar LM] REEM, Multiple Sclerosis Spanish Network, Instituto de Salud Carlos III, Madrid, Spain. Immunology Department, Ramon y Cajal University Hospital, IRYCIS, Madrid, Spain. [Robles-Cedeño R, Ramió-Torrentà Ll] Girona Neuroimmumology and Multiple Sclerosis Unit, Neurology Department, Hospital Universitari de Girona Doctor Josep Trueta, Institut Català de la Salut (ICS), Girona, Spain. Neurodegeneration and Neuroimflammation Research Group, Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta, Salt, Spain. Medical Sciences Department, University of Girona, Girona, Spain. REEM, Multiple Sclerosis Spanish Network, Instituo de Salud Carlos III, Madrid, Spain. [Gich J] Girona Neuroimmumology and Multiple Sclerosis Unit, Neurology Department, Hospital Universitari de Girona Doctor Josep Trueta, Institut Català de la Salut (ICS), Girona, Spain. Neurodegeneration and Neuroimflammation Research Group, Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta, Salt, Spain. Medical Sciences Department, University of Girona, Girona, Spain

Hospital Universitari de Girona Dr Josep Trueta

Data de publicació

2023-03-16T10:50:12Z

2021-12

Resum

Bandes oligoclonals; Esclerosi múltiple; Disfunció cognitiva

Bandas oligoclonales; Esclerosis múltiple; Disfunción cognitiva

Oligoclonal bands; Multiple sclerosis; Cognitive dysfunction

Background: An association has been found between the presence of lipid-specific oligoclonal IgM bands (LS-OCMB) in cerebrospinal fluid and a more severe clinical multiple sclerosis course. Objective: To investigate lipid-specific oligoclonal IgM bands as a prognostic biomarker of cognitive impairment in the early stages of multiple sclerosis. Methods: Forty-four patients underwent neuropsychological assessment at baseline and 4 years. Cognitive performance at follow-up was compared adjusting by age, education, anxiety-depression, and baseline performance. Results: LS-OCMB+ patients only performed worse for Long-Term Storage in the Selective Reminding Test (p = .018). Conclusion: There are no remarkable cognitive differences between LS-OCMB- and LS-OCMB+ patients in the early stages of MS.

Tipus de document

Article

Versió publicada

Llengua

Anglès

Matèries i paraules clau

Esclerosi múltiple; Marcadors bioquímics; Trastorns de la cognició; CHEMICALS AND DRUGS::Biological Factors::Biomarkers::Oligoclonal Bands; DISEASES::Immune System Diseases::Autoimmune Diseases::Autoimmune Diseases of the Nervous System::Demyelinating Autoimmune Diseases, CNS::Multiple Sclerosis; PSYCHIATRY AND PSYCHOLOGY::Mental Disorders::Neurocognitive Disorders::Cognition Disorders::Cognitive Dysfunction; COMPUESTOS QUÍMICOS Y DROGAS::factores biológicos::biomarcadores::bandas oligoclonales; PSIQUIATRÍA Y PSICOLOGÍA::trastornos mentales::trastornos neurocognitivos::trastornos cognitivos::disfunción cognitiva; ENFERMEDADES::enfermedades del sistema nervioso::enfermedades autoinmunitarias del sistema nervioso::enfermedades autoinmunes desmielinizantes del SNC::esclerosis múltiple

Publicat per

Wiley

Documents relacionats

Brain and Behavior;11(12)

https://doi.org/10.1002/brb3.2405

Citació recomanada

Aquesta citació s'ha generat automàticament.

Exportar

DIDL MARC MARC_CCUC METS OAI_DC ORE QDC RDF

Drets

Attribution 4.0 International

http://creativecommons.org/licenses/by/4.0/

Aquest element apareix en la col·lecció o col·leccions següent(s)

Articles científics - HGJT [47]